100 related articles for article (PubMed ID: 10374339)
21. Detection of apoptotic cells in archival tissue from diffuse astrocytomas using a monoclonal antibody to single-stranded DNA.
Korkolopoulou PA; Konstantinidou AE; Patsouris ES; Christodoulou PN; Thomas-Tsagli EA; Davaris PS
J Pathol; 2001 Mar; 193(3):377-82. PubMed ID: 11241419
[TBL] [Abstract][Full Text] [Related]
22. [A study on the relationship among activity of PDGFBB autocrine loop, cell proliferation and apoptosis in human glioma cells].
Yu S; Pu P; Jiang D
Zhonghua Bing Li Xue Za Zhi; 1998 Oct; 27(5):352-5. PubMed ID: 11245010
[TBL] [Abstract][Full Text] [Related]
23. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen.
Ishibashi M; Taguchi A; Sugita Y; Morita S; Kawamura S; Umezaki N; Shigemori M; Hayabuchi N
J Nucl Med; 1995 Dec; 36(12):2201-6. PubMed ID: 8523105
[TBL] [Abstract][Full Text] [Related]
24. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
[TBL] [Abstract][Full Text] [Related]
25. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
26. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
27. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
28. [p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis].
Ye S; Zhong X; Chen Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):326-9. PubMed ID: 11783119
[TBL] [Abstract][Full Text] [Related]
29. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
[TBL] [Abstract][Full Text] [Related]
31. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
Facoetti A; Ranza E; Nano R
Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
[TBL] [Abstract][Full Text] [Related]
32. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
33. [Regarding the article by W. Berny i wsp. entitled "Expression of PCNA, Ki-67, AgNOR and p53 protein in brain glial tumors", published in the Polish Journal of Neurology and Neurosurgery no. 6/2004].
Słowiński J
Neurol Neurochir Pol; 2005; 39(3):255-6; author reply 256. PubMed ID: 15981169
[No Abstract] [Full Text] [Related]
34. [Immunohistochemical changes in apoptosis in glioblastoma of the cerebral hemispheres].
Korshunov AG; Sycheva RV; Golanov AV
Arkh Patol; 1998; 60(3):23-7. PubMed ID: 9702296
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
36. Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma.
Li B; Qi XQ; Chen X; Huang X; Liu GY; Chen HR; Huang CG; Luo C; Lu YC
Brain Res; 2010 Sep; 1352():200-7. PubMed ID: 20599806
[TBL] [Abstract][Full Text] [Related]
37. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
38. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
[TBL] [Abstract][Full Text] [Related]
39. p53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomas.
O'Reilly PE; Raab SS; Niemann TH; Rodgers JR; Robinson RA
Mod Pathol; 1997 Feb; 10(2):91-7. PubMed ID: 9127313
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
